Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer
NCT03516045Phase 2Unknown
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Apr 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Xiangya Hospital, Central South University. Primary endpoint: Standardized Uptake Value (SUVmax/SUVmean) at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT03516045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516045.